These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17170499)

  • 1. Development and progression of retinopathy after inpatient management of diabetes.
    Kawasaki S; Hasegawa O; Satoh S; Saito T; Ishio H; Fukushima H; Kato S; Yamashita H; Terauchi Y; Sekihara H
    Intern Med; 2006; 45(22):1267-71. PubMed ID: 17170499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
    Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
    Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM.
    Henricsson M; Janzon L; Groop L
    Diabetes Care; 1995 Dec; 18(12):1571-6. PubMed ID: 8722053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
    Rosenstock J; Fonseca V; McGill JB; Riddle M; Hallé JP; Hramiak I; Johnston P; Davis M
    Diabetologia; 2009 Sep; 52(9):1778-88. PubMed ID: 19526210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin treatment of elderly type 2 diabetic patients: effects on retinopathy.
    Tovi J; Ingemansson SO; Engfeldt P
    Diabetes Metab; 1998 Nov; 24(5):442-7. PubMed ID: 9881243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin therapy on progression of retinopathy in noninsulin-dependent diabetes mellitus.
    Roysarkar TK; Gupta A; Dash RJ; Dogra MR
    Am J Ophthalmol; 1993 May; 115(5):569-74. PubMed ID: 8488908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China.
    Liu Y; Yang J; Tao L; Lv H; Jiang X; Zhang M; Li X
    BMJ Open; 2017 Sep; 7(9):e016280. PubMed ID: 28864696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
    Ozmen B; Boyvada S
    J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM; Matthews DR
    Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge.
    Wexler DJ; Beauharnais CC; Regan S; Nathan DM; Cagliero E; Larkin ME
    Diabetes Res Clin Pract; 2012 Nov; 98(2):249-56. PubMed ID: 23036785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM.
    Nagi DK; Pettitt DJ; Bennett PH; Klein R; Knowler WC
    Diabet Med; 1997 Jun; 14(6):449-56. PubMed ID: 9212309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of glycaemic control on the quantitative characteristics of retinopathy lesions in patients with type 2 diabetes mellitus: 10-year follow-up study.
    Kalesnykiene V; Sorri I; Voutilainen R; Uusitupa M; Niskanen L; Uusitalo H
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):335-41. PubMed ID: 19043734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study.
    Osataphan S; Chalermchai T; Ngaosuwan K
    J Diabetes; 2017 Mar; 9(3):267-274. PubMed ID: 27092709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of basal insulin supplement therapy on diabetic retinopathy in short-duration type 2 diabetes: A one-year randomized parallel-group trial.
    Mu PW; Tang XX; Tan Y; Wang YN; Lin S; Wang MM; Shu J; Wang J; Zhang YJ; Liang H; Lin BR; Cai MY; Chen YM
    J Diabetes; 2019 Dec; 11(12):949-957. PubMed ID: 30973204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes.
    Fujishima Y; Maeda N; Inoue K; Kashine S; Nishizawa H; Hirata A; Kozawa J; Yasuda T; Okita K; Imagawa A; Funahashi T; Shimomura I
    Cardiovasc Diabetol; 2012 Sep; 11():107. PubMed ID: 22973968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients.
    Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    Diabetes Res Clin Pract; 2011 Feb; 91(2):e40-2. PubMed ID: 21035886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic variability and diabetes retinopathy: a missing link.
    Hsu CR; Chen YT; Sheu WH
    J Diabetes Complications; 2015 Mar; 29(2):302-6. PubMed ID: 25534877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between Cystatin C and retinopathy of type-two diabetes mellitus patients.
    Qian C; Wan GM; Yan PS; Wang WZ; Liang SZ; Dong Y
    J Biol Regul Homeost Agents; 2017; 31(1):99-103. PubMed ID: 28337877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].
    Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.